BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24497999)

  • 1. Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials.
    Xu AM; Huang L; Liu W; Gao S; Han WX; Wei ZJ
    PLoS One; 2014; 9(1):e86941. PubMed ID: 24497999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy followed by surgery versus surgery alone for colorectal cancer: meta-analysis of randomized controlled trials.
    Huang L; Li TJ; Zhang JW; Liu S; Fu BS; Liu W
    Medicine (Baltimore); 2014 Dec; 93(28):e231. PubMed ID: 25526442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
    Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
    World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
    Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
    World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials.
    Xiong B; Ma L; Cheng Y; Zhang C
    Eur J Surg Oncol; 2014 Oct; 40(10):1321-30. PubMed ID: 25239442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Neoadjuvant chemotherapy versus none for resectable gastric cancer.
    Wu AW; Xu GW; Wang HY; Ji JF; Tang JL
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005047. PubMed ID: 17943834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy versus none for resectable gastric cancer.
    Wu AW; Xu GW; Wang HY; Ji JF; Tang JL
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005047. PubMed ID: 17443566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy brings more survival benefits than postoperative chemotherapy for resectable gastric cancer: a Meta-analysis of randomized controlled trials.
    Hu Y; Hu D; Li W; Yu X
    J BUON; 2019; 24(1):201-214. PubMed ID: 30941971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer.
    Xiong BH; Cheng Y; Ma L; Zhang CQ
    Cancer Invest; 2014 Jul; 32(6):272-84. PubMed ID: 24800782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials.
    Liao Y; Yang ZL; Peng JS; Xiang J; Wang JP
    J Gastroenterol Hepatol; 2013 May; 28(5):777-82. PubMed ID: 23425049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy followed by surgery versus upfront surgery in non-metastatic non-small cell lung cancer: systematic review and meta-analysis of randomized controlled trials.
    Zhang XN; Huang L
    Oncotarget; 2017 Oct; 8(52):90327-90337. PubMed ID: 29163832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for nonmetastatic esophago-gastric adenocarcinomas: a systematic review and meta-analysis.
    Zhang CD; Zeng YJ; Li HW; Zhao ZM; Zhang JK; Dai DQ
    Cancer Invest; 2013 Jul; 31(6):421-31. PubMed ID: 23758189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.
    Gosavi R; Chia C; Michael M; Heriot AG; Warrier SK; Kong JC
    Int J Colorectal Dis; 2021 Oct; 36(10):2063-2070. PubMed ID: 33945007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.
    Miao ZF; Liu XY; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Xu H; Xu HM
    BMC Cancer; 2018 Jan; 18(1):118. PubMed ID: 29385994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.
    Li W; Qin J; Sun YH; Liu TS
    World J Gastroenterol; 2010 Nov; 16(44):5621-8. PubMed ID: 21105197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-targeted first-line therapy for advanced gastric cancer.
    Song H; Zhu J; Lu D
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011461. PubMed ID: 27432490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials.
    Zhao X; Ren Y; Hu Y; Cui N; Wang X; Cui Y
    PLoS One; 2018; 13(8):e0202185. PubMed ID: 30138325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
    Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Nowak K; Kieser M; Slanger TE; Burmeister B; Kelsen D; Niedzwiecki D; Schuhmacher C; Urba S; van de Velde C; Walsh TN; Ychou M; Jensen K
    Eur J Surg Oncol; 2017 Aug; 43(8):1550-1558. PubMed ID: 28551325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
    Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
    BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.